Login

Steven van Rijswijk, CEO of ING, discusses global business and market trends in an interview with CNBC at the World Economic Forum. 00:10:00

Share On Facebook Share On Twitter

Steven van Rijswijk, CEO of ING

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Jay Taylor and Brian Skanderbeg are interviewed by GFG Resources at the Metals Investor Forum | Brian Skanderbeg, President & CEO, GFG Resources Inc. (IE)
00:10:00
Kroll's Global Valuation Advisory: Growth and Differentiators in APAC
00:10:00
AI researchers investing in AI deeptech and the future of work|Josh Albrecht,General Partner,Outset Capital
00:10:00
Diamond Miner with Strategic Alliance with Tiffany & Co. Nears Production
00:10:00
Onshore vs. Offshore: Francois Verlaine’s Insights on Fund Structures | MD, Standard Chartered
00:10:00
Enea partners with Last Energy to develop low-emission SMR reactors in Poland, in line with national energy objectives | Paweł Majewski, CEO, Enea SA.
00:10:00
Cargotec CFO Addresses Investor Queries: Q1 2024 Insights | Mikko Puolakka - CFO of Cargotec
00:10:00
Watch CNBC's full interview with Orange CEO Christel Heydemann discussing telecommunications and technology trends.
00:10:00
Watch CEO Chris Bursey's complete OTCQXVideo interview as Remark Holdings, Inc. is welcomed with enthusiasm.
00:10:00
Exploring the Riches of Sinaloa: GR Silver's Mining Endeavors in Mexico
00:10:00
Understanding the Dynamics of Financial Regulation in Emerging Markets |Brandon White, Managing Director, Charlesbank Capital Partners.
00:10:00
Revolutionizing Art Investment Through Technology, Transparency, and Blue-Chip Access|Tony Dalwood,CEO,Gresham House Ventures

© 2017 - Neuhu+